Cambrian Biopharma Company
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.
As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
Invests into
Investors
Founded Date:
2019-01-01
Last Funding Date:
2026-02-24
Industry:
Quantum Biology
Total Funding:
190800000
Headquarters:
New York,New York,United States,North America
Employee Number:
11-50
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Late Stage Venture
Funding Total Value:
190800000
Last Funding Total Usd:
30800000
Last Funding Total Currency:
USD
Last Funding Total Value:
30800000
Founders:
Christian Angermayer,James Peyer,Sebastian Brunemeier
Phone Number:
(516) 962-3186